HERA, WHO and GARDP join forces to counter the growing threat of antimicrobial resistance

Representatives from the European Commission’s Health Emergency Preparedness and Response Authority (HERA), WHO and GARDP met in Geneva on 11 May, as part of the first Project Steering Committee meeting, to kick-off the new action focusing on countering the growing threat of antimicrobial resistance (AMR). 

HERA is providing WHO and GARDP with € 8 million to fund the AMR action over the next three years to ensure sustainable access to AMR treatments and promote their responsible use and affordability, while also driving research and prioritization of the search for new antimicrobials.

As part of this action, GARDP will receive € 5 million for its late-stage clinical development, regulatory and access activities focusing on serious bacterial infections, sexually transmitted infections and children’s antibiotics.